BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23111358)

  • 1. Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.
    Shamseddine AI; Mukherji D; Melki C; Elias E; Eloubeidi M; Dimassi H; Khalife M; Abou-Alfa G; O'Reilly E; Faraj W
    Am J Clin Oncol; 2014 Feb; 37(1):13-8. PubMed ID: 23111358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.
    Bhatti I; Peacock O; Awan AK; Semeraro D; Larvin M; Hall RI
    World J Surg; 2010 Apr; 34(4):768-75. PubMed ID: 20052471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer.
    Mirkin KA; Hollenbeak CS; Wong J
    J Surg Res; 2017 Dec; 220():12-24. PubMed ID: 29180173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas.
    Pomianowska E; Westgaard A; Mathisen Ø; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Jan; 20(1):233-41. PubMed ID: 22893118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma.
    Huebner M; Kendrick M; Reid-Lombardo KM; Que F; Therneau T; Qin R; Donohue J; Nagorney D; Farnell M; Sarr M
    J Gastrointest Surg; 2012 May; 16(5):920-6. PubMed ID: 22421988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
    Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
    Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Hoffman JP
    Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.
    Ashfaq A; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
    J Gastrointest Surg; 2014 Nov; 18(11):1929-35. PubMed ID: 24916590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the lymph node ratio after resection of periampullary carcinomas.
    Farid SG; Falk GA; Joyce D; Chalikonda S; Walsh RM; Smith AM; Morris-Stiff G
    HPB (Oxford); 2014 Jun; 16(6):582-91. PubMed ID: 23777362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
    Sierzega M; Popiela T; Kulig J; Nowak K
    Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between the index of lymph node metastasis and the prognosis of pancreatic cancer patients after R0 resection].
    Ren H; Wang CF
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):474-479. PubMed ID: 32575943
    [No Abstract]   [Full Text] [Related]  

  • 18. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery.
    Philips P; Dunki-Jacobs E; Agle SC; Scoggins C; McMasters KM; Martin RC
    HPB (Oxford); 2014 Dec; 16(12):1051-5. PubMed ID: 25123504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
    Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
    Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.